The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2, two-group, two-stage study of avelumab in patients (pts) with microsatellite stable (MSS), microsatellite instable (MSI), and polymerase epsilon (POLE) mutated recurrent/persistent endometrial cancer (EC).
 
Panagiotis A. Konstantinopoulos
Consulting or Advisory Role - AstraZeneca; Merck; Pfizer/EMD Serono; Vertex
 
Joyce F. Liu
Consulting or Advisory Role - Clovis Oncology; Mersana; Tesaro
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Regeneron (Inst); Surface Oncology (Inst); Tesaro (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Weixiu Luo
No Relationships to Disclose
 
Carolyn N. Krasner
Research Funding - Cerulean Pharma
 
Jeffrey Joseph Ishizuka
Stock and Other Ownership Interests - Jounce Therapeutics; Kronos Bio
Consulting or Advisory Role - Kronos Bio; Rheos Medicines
Patents, Royalties, Other Intellectual Property - Dana-Farber patent on approaches to target ADAR1 for cancer; Dana-Farber patent on approaches to target ADAR1 for cancer (Inst)
 
Allison Ann Gockley
No Relationships to Disclose
 
Mary K. Buss
Honoraria - UpToDate
 
Susana M. Campos
Consulting or Advisory Role - Clovis Oncology
 
Elizabeth Stover
Patents, Royalties, Other Intellectual Property - Patent pending
 
Alexi A. Wright
Honoraria - CVS Health
 
Whitfield Board Growdon
Consulting or Advisory Role - Tesaro
Research Funding - Tesaro (Inst)
 
Jennifer Curtis
No Relationships to Disclose
 
Ariana Peralta
No Relationships to Disclose
 
Patrice Basada
No Relationships to Disclose
 
Roxanne Quinn
No Relationships to Disclose
 
Kathryn P. Gray
Stock and Other Ownership Interests - DVAX
 
Richard T. Penson
Honoraria - Abbvie; Amgen; AstraZeneca; Baxalta; Clovis Oncology; Eisai; Genentech; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Baxalta; Care4ward; Clovis Oncology; Eisai; Genentech; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech; Tesaro; Vascular Biogenics
Other Relationship - Abbvie
 
Stephen A. Cannistra
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Corcept Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
 
Ursula A. Matulonis
Consulting or Advisory Role - 2X Oncology; Fujifilm; Geneos; Immunogen; Merck; Mersana; Myriad Genetics
Research Funding - Merck; Novartis; Syndax; Tesaro